WAH WAH AUNG

Dr. WAH WAH AUNG

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
PEPhyu Win Ei
Phyu Win Ei
WAWAH WAH AUNG
WAH WAH AUNG
JLJongseok LEE
Jongseok LEE
GCGo-Eun Choi
Go-Eun Choi
CCChulhun L. Chang
Chulhun L. Chang
Ei PW, et al. J Korean Med Sci. 2016 Nov;31(11):1673-1683. https://doi.org/10.3346/jkms.2016.31.11.1673

1 September 2015 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
WAWAH WAH AUNG
WAH WAH AUNG
PEPhyu Win Ei
Phyu Win Ei
WNWint Wint Nyunt
Wint Wint Nyunt
TSThyn Lei Swe
Thyn Lei Swe
TLThandar Lwin
Thandar Lwin
CCChulhun L. Chang
Chulhun L. Chang
Tuberculosis (TB) is one of the most serious health problems in Myanmar. Because TB drug resistance is associated with genetic mutation(s) relevant to responses to each drug, genotypic methods for detecting these mutations have been proposed to overcome the limitations of classic phenotypic drug susceptibility testing (DST). We explored the current estimates of drug-resistant TB and evaluated the usefulness of genotypic DST in Myanmar. We determined the drug susceptibility of Mycobacterium tuberculosis isolated from sputum smear-positive patients with newly diagnosed pulmonary TB at two main TB centers in Myanmar during 2013 by using conventional phenotypic DST and the GenoType MTBDRplus assay (Hain Lifescience, Germany). Discrepant results were confirmed by sequencing the genes relevant to each type of resistance (rpoB for rifampicin; katG and inhA for isoniazid). Of 191 isolates, phenotypic DST showed that 27.7% (n=53) were resistant to at least one first-line drug and 20.9% (n=40) were resistant to two or more, including 18.3% (n=35) multidrug-resistant TB (MDR-TB) strains. Monoresistant strains accounted for 6.8% (n=13) of the samples. Genotypic assay of 189 isolates showed 17.5% (n=33) MDR-TB and 5.3% (n=10) isoniazid-monoresistant strains. Genotypic susceptibility results were 99.5% (n=188) concordant and agreed almost perfectly with phenotypic DST (kappa=0.99; 95% confidence interval 0.96-1.01). The results highlight the burden of TB drug resistance and prove the usefulness of the genotypic DST in Myanmar.

1 December 2020 in Tuberculosis
Verified
Journal Article
Closed access
PEPhyu Win Ei
Phyu Win Ei
AMAye Su Mon
Aye Su Mon
MHMi Mi Htwe
Mi Mi Htwe
SWSu Mon Win
Su Mon Win
KAKay Thi Aye
Kay Thi Aye
WAWAH WAH AUNG
WAH WAH AUNG

1 May 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
MWMo Mo Win
Mo Mo Win
THThaung Hla
Thaung Hla
KPKhin Phyu Phyu
Khin Phyu Phyu
WAWAH WAH AUNG
WAH WAH AUNG
KWKyi Kyi Nyein Win
Kyi Kyi Nyein Win
David DanceDavid Dance
David Dance
Melioidosis is a tropical infection, first described in Myanmar but now rarely diagnosed there, which is widespread in Southeast Asia. The infection is predominantly acquired by people and animals through contact with soil or water. This study aimed to detect the causative organism, Burkholderia pseudomallei, in environmental samples from farms in Thanlyin and Hmawbi townships near Yangon, Myanmar. One hundred and twenty soil samples and 12 water samples were collected and processed using standard microbiological methods. Burkholderia species were isolated from 50 of the 120 (42%) soil samples but none of the water samples. Arabinose assimilation was tested to differentiate between B. pseudomallei and the nonpathogenic Burkholderia thailandensis, and seven of 50 isolates (14%) were negative. These were all confirmed as B. pseudomallei by a species-specific multiplex polymerase chain reaction (PCR). This is the first study to detect environmental B. pseudomallei in Myanmar and confirms that melioidosis is still endemic in the Yangon area.

8 November 2017 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
ARAmonrattana Roobthaisong
Amonrattana Roobthaisong
WAWAH WAH AUNG
WAH WAH AUNG
AHAye Aye Han
Aye Aye Han
WKWatcharaporn Kamjumphol
Watcharaporn Kamjumphol
SHShigeyuki Hamada
Shigeyuki Hamada
WWWarawan Wongboot
Warawan Wongboot
Cholera, caused by Vibrio cholerae, remains a global threat to public health. In Myanmar, the availability of published information on the occurrence of the disease is scarce. We report here that cholera incidence in Mandalay generally exhibited a single annual peak, with an annual average of 312 patients with severe dehydration over the past 5 years (since 2011) and was closely associated with the rainy season. We analyzed cholera outbreaks, characterized 67 isolates of V. cholerae serogroup O1 in 2015 from patients from Mandalay, and compared them with 22 V. cholerae O1 isolates (12 from Mandalay and 10 from Yangon) in 2014. The isolates carried the classical cholera toxin B subunit (ctxB), the toxin-coregulated pilus A (tcpA) of Haitian type, and repeat sequence transcriptional regulator (rstR) of El Tor type. Two molecular typing methods, pulsed-field gel electrophoresis and multiple-locus variable-number tandem repeat analysis (MLVA), differentiated the 89 isolates into seven pulsotypes and 15 MLVA profiles. Pulsotype Y15 and one MLVA profile (11, 7, 7, 16, 7) were predominantly found in the isolates from cholera outbreaks in Mandalay, 2015. Pulsotypes Y11, Y12, and Y15 with some MLVA profiles were detected in the isolates from two remote areas, Mandalay and Yangon, with temporal changes. These data suggested that cholera spread from the seaside to the inland area in Myanmar.

20 December 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
AMAye Su Mon
Aye Su Mon
PEPhyu Win Ei
Phyu Win Ei
MHMi Mi Htwe
Mi Mi Htwe
MNMyat Htut Nyunt
Myat Htut Nyunt
SWSu Mon Win
Su Mon Win
WAWAH WAH AUNG
WAH WAH AUNG